Anastasios Arima Buys 138,720 Shares of IperionX (NASDAQ:IPX) Stock

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) CEO Anastasios Arima bought 138,720 shares of the business’s stock in a transaction on Friday, July 10th. The shares were bought at an average cost of $3.58 per share, for a total transaction of $496,617.60. Following the completion of the acquisition, the chief executive officer directly owned 12,455,502 shares in the company, valued at approximately $44,590,697.16. This trade represents a 1.13% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Anastasios Arima also recently made the following trade(s):

  • On Tuesday, April 28th, Anastasios Arima purchased 110,000 shares of IperionX stock. The stock was purchased at an average price of $4.49 per share, for a total transaction of $493,900.00.

IperionX Trading Up 3.3%

IPX stock opened at $25.49 on Wednesday. IperionX Limited Sponsored ADR has a 12-month low of $21.66 and a 12-month high of $61.45. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03. The company’s fifty day simple moving average is $33.94 and its 200 day simple moving average is $37.34.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. BTIG Research raised their price objective on IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, June 5th. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research report on Tuesday, April 21st. Roth Capital reiterated a “buy” rating on shares of IperionX in a research report on Monday, June 8th. Finally, Alliance Global Partners reiterated a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Five equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $60.33.

View Our Latest Report on IPX

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC increased its stake in shares of IperionX by 40.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after acquiring an additional 483 shares in the last quarter. DLD Asset Management LP purchased a new position in IperionX in the 1st quarter worth about $260,000. Private Advisor Group LLC grew its position in IperionX by 69.9% in the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after purchasing an additional 25,964 shares during the period. State of Tennessee Department of Treasury bought a new stake in shares of IperionX in the fourth quarter worth $119,000. Finally, XTX Topco Ltd purchased a new position in shares of IperionX in the fourth quarter worth approximately $302,000. Hedge funds and other institutional investors own 2.76% of the company’s stock.

More IperionX News

Here are the key news stories impacting IperionX this week:

IperionX Company Profile

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high?purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

Featured Articles

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.